CORC

在结果中检索

CORC

浏览/检索结果: 共134条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
EFFICACY, PHARMACOKINETICS, SAFETY AND IMMUNOGENICITY OF THE BIOSIMILAR HS016 IN COMPARISON WITH ADALIMUMAB IN CHINESE PATIENTS WITH ANKYLOSING SPONDYLITIS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PHASE 3 TRIAL 会议论文
ANNALS OF THE RHEUMATIC DISEASES, 2019-06-01
作者:  Su, Jinmei;  Li Mengtao;  Zeng, Xiaofeng
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
EFFICACY, PHARMACOKINETICS, SAFETY AND IMMUNOGENICITY OF THE BIOSIMILAR HS016 IN COMPARISON WITH ADALIMUMAB IN CHINESE PATIENTS WITH ANKYLOSING SPONDYLITIS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PHASE 3 TRIAL 期刊论文
2019, 卷号: 78, 页码: 894-894
作者:  Su, Jinmei;  Li Mengtao;  Zeng, Xiaofeng
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trial 期刊论文
2019, 卷号: 11, 期号: 1, 页码: e12344
作者:  Wang, XuYi;  Jiang, Haifeng;  Zhao, Min;  Li, Jing;  Gray, Frank
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocol 期刊论文
2019, 卷号: 19, 期号: 1, 页码: 397
作者:  Li, Chen;  Wang, Xiaomin;  Wang, Xin;  Han, Chun;  Wang, Ping
收藏  |  浏览/下载：14/0  |  提交时间：2020/01/03
Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial 期刊论文
2019, 卷号: 52, 期号: 1, 页码: 35-44
作者:  Yuan, Jinyi;  Mo, Biwen;  Ma, Zhuang;  Lv, Yuan;  Cheng, Shih-Lung
收藏  |  浏览/下载：30/0  |  提交时间：2020/01/03
Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 months of follow-up 期刊论文
2019, 卷号: 37, 期号: 6, 页码: 889-897
作者:  Chen, Wen;  Zhao, Yun;  Xie, Xing;  Liu, Jihong;  Li, Jingran
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial 期刊论文
2019, 卷号: 14, 期号: 5, 页码: 867-875
作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie
收藏  |  浏览/下载：14/0  |  提交时间：2020/01/03
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial 期刊论文
2019, 卷号: 24, 期号: 8, 页码: E702-E708
作者:  Zhou, Ai-Ping;  Bai, Yuxian;  Song, Yan;  Luo, Hong;  Ren, Xiu-Bao
收藏  |  浏览/下载：18/0  |  提交时间：2020/01/03
Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 16
作者:  Huang, Jing;  Xu, Binghe;  Liu, Ying;  Huang, Junxing;  Lu, Ping
收藏  |  浏览/下载：31/0  |  提交时间：2020/01/03
Efficacy and safety of insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase III, open-label, 2:1 randomized, treat-to-target trial 期刊论文
2019, 卷号: 21, 期号: 7, 页码: 1652-1660
作者:  Yang, Wenying;  Ma, Jianhua;  Hong, Tianpei;  Liu, Ming;  Miao, Heng
收藏  |  浏览/下载：16/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace